Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107.4 EUR | -0.48% | -2.38% | +8.41% |
06-18 | T. Rowe Price Unveils New, Patent-Pending Framework | CI |
06-12 | Goldman Sachs Raises T. Rowe Price's PT to $113 From $110 | MT |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company's enterprise value to sales, at 3.24 times its current sales, is high.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.41% | 25.75B | - | ||
-3.02% | 117B | A- | ||
+1.34% | 94.38B | C+ | ||
+26.70% | 67.18B | C | ||
+7.06% | 64.45B | - | B+ | |
+15.06% | 44.79B | C+ | ||
+12.47% | 42.43B | A- | ||
+26.64% | 37.37B | A- | ||
-4.47% | 22.29B | A- | ||
-0.28% | 18.39B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- TROW Stock
- TR1 Stock
- Ratings T. Rowe Price Group Inc.